Dr. Ralph de la Torre is the CEO of CareMax, Inc., a company focused on transforming healthcare delivery. Born on May 10, 1968, he holds a Doctor of Medicine degree from the University of Miami, giving him a solid background...

Dr. Ralph de la Torre is the CEO of CareMax, Inc., a company focused on transforming healthcare delivery. Born on May 10, 1968, he holds a Doctor of Medicine degree from the University of Miami, giving him a solid background for leading a healthcare organization. He was appointed as a board director of CareMax in late 2022, shortly after the company acquired a Medicare value-based care business, showcasing his strategic involvement in company growth. In 2023, Dr. de la Torre's total compensation was set at $1 million, which reflects his role in pushing the company's performance metrics like revenue growth and operational efficiency. On the stock side, 2022 saw him vested 20,000 shares, a significant investment that highlights his belief in the company's potential. Overall, Dr. de la Torre's blend of medical expertise and leadership experience is helping CareMax adapt to the changing landscape of healthcare.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other CareMax, Inc. CEOs

C

Dr. Ralph de la Torre

Ex-CEO of CareMax, Inc.

Education

Doctor of Medicine from the University of Miami

Field of Expertise

Healthcare & Life Sciences - Healthcare

Sector of Economy

Healthcare

Born

May 10, 1968 - 57 years ago

CEO of CareMax, Inc. for

0 years 10 months (Nov 2022 - Oct 2023)

Previous Experience

Chairman and CEO of Steward Health Care System LLC

Rivals

Competitors/colleagues of Dr. Ralph de la Torre

Holdings

See how much did Dr. Ralph de la Torre make over time.

As of 2023, Dr. Ralph de la Torre's value in CareMax, Inc. shares went up and down based on the company's performance. In 2022, he saw 20,000 shares vest, which were valued at $300,000, helping him align his financial interest...

As of 2023, Dr. Ralph de la Torre's value in CareMax, Inc. shares went up and down based on the company's performance. In 2022, he saw 20,000 shares vest, which were valued at $300,000, helping him align his financial interest with the company's success. His personal wealth has been significantly tied to these shares, especially given the company's recent acquisition that opened new growth avenues. His early stakes are notable, as they suggest that he has seen an increase in his wealth tied to this movement in stock performance. Following his strategic initiatives at CareMax, we can expect more fluctuations as the healthcare market remains dynamic.

Loading...

Insider Trading

See recent insider trades of Dr. Ralph de la Torre.

No insider trades found for this CEO.

Compensation History

See how much did Dr. Ralph de la Torre make over time.

Dr. Ralph de la Torre's compensation package in 2023 was $1 million. This includes a $500,000 salary and a performance bonus of $150,000, indicating a strong focus on achieving company goals. Additionally, he received $300,000 from vested stock as part of a long-term incentive plan meant to motivate executives over a few years. Other benefits, like health care and retirement contributions, also added about $50,000 to his total compensation. This package not only reflects his value to CareMax but also ensures his interests are tightly connected to the company's growth and performance metrics that matter to investors. It is designed to attract and keep talent in the healthcare sector while focusing on long-term growth, where Dr. de la Torre's leadership is key.

Year

2023

Total Compensation

$1.00M

Salary

$500.00K

Board Justification

The compensation philosophy is designed to align the CEO's interests with those of shareholders, focusing on long-term performance and retention of key executives.

Bonus

$150.00K

Board Justification

The bonus is based on the achievement of specific performance metrics related to company growth and operational efficiency for the year 2023.

Other

$50.00K

Board Justification

Other compensation includes health benefits, retirement contributions, and perquisites provided to the CEO in 2023.

Restricted Stock

$300.00K(10K RSU)

Board Justification

The stock that vested in 2023 is part of the long-term incentive plan, which is tied to the company's performance over a three-year period, with 10,000 shares vesting this year.

Performance Metrics

Performance metrics include revenue growth, EBITDA margins, and patient satisfaction scores.

Other CareMax, Inc. CEOs

Here are other CEOs of CareMax, Inc.

Carlos A. de Solo

Founder and Ex-CEO of CareMax, Inc.

June 2021 - November 2022

Paul Rundell

CEO of CareMax, Inc.

June 2024 - Present